The Evidence Base Post 30 March 2026 Industry perspectives on the first Joint Clinical Assessments under EU HTA: insights from Nicole Yurgin The Evidence Base Register with The Evidence Base for free to access this content Already have an account? Sign in By registering with The Evidence Base, you will receive our weekly round-up and other relevant editorial content. You can opt-out at any time. View our privacy policy here.